Proventys' advanced decision support product framework includes two core, complementary areas:

The Proventys CDS System™ - a unique, web-based solution that dynamically automates and presents practice guidelines and other evidence-based tools within the clinical workflow to help clincians optimize and personalize decision-making.  Current product development efforts are focused particularly on oncology and bringing highly practical solutions to community-based practices.

The Proventys PDx System™ - a novel web-based solution that generates and delivers validated predictive tests (PDx) that help quantify and assess a patient's risk of an adverse event, potential disease onset or progression, or likely response to a given therapy.  The company is targeting a range of clinical areas where the use of the Proventys PDx System™ and predictive test could have a profound impact on patient outcomes including specific opportunities within oncology and cardiology.

Proventys PDx Oncology™ is under review by the FDA (de novo); not available for sale in the United States.